Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Dermatology

Genetics and the ARCI Spectrum: Understanding the Cause

At a Glance

CIE is an inherited skin-barrier disorder within the ARCI spectrum. Genetic testing may identify the gene involved, but it cannot always predict severity or appearance. If both parents carry a disease-causing variant in the same gene, each pregnancy has a 25% chance of ichthyosis.

Understanding the diagnosis of Congenital Ichthyosiform Erythroderma (CIE) involves looking at the “blueprint” of the skin. CIE is not a standalone condition; it is part of a group of skin disorders called Autosomal Recessive Congenital Ichthyosis (ARCI) [1].

The ARCI Spectrum: CIE vs. Lamellar Ichthyosis

Within the ARCI spectrum, doctors often describe two main “ends” of the presentation: CIE and Lamellar Ichthyosis (LI). It is important to know that these are not strictly separate diseases, but rather different points on the same clinical spectrum [2].

  • CIE (Congenital Ichthyosiform Erythroderma): Characterized by significant erythema (generalized skin redness) and fine, whitish scales [1][3]. In one study, patients with CIE had higher scores for redness compared to those with LI [1].
  • LI (Lamellar Ichthyosis): Typically involves less redness but features thicker, darker, plate-like scales [1][4].
  • The Overlap: Many individuals fall somewhere in the middle, showing features of both. Some even start as one and transition toward the other as they grow [5][6].

The Biology of the Barrier

In healthy skin, the outer layer acts like a brick wall. The skin cells are the “bricks,” and a mixture of fats called lipids acts as the “mortar” that keeps the wall waterproof and strong. In ARCI, mutations in specific genes disrupt how this “mortar” is made or applied [7].

One of the most critical components of this mortar is a specialized lipid called acylceramide. If the skin cannot produce or process these lipids correctly, the barrier fails. This leads to the characteristic scaling as the body tries to compensate for the “leaky” barrier, as well as the redness caused by underlying inflammation [8][9].

The Genes Behind the Diagnosis

Genetic testing is often used to help identify the molecular cause of the disease, though clinical diagnosis remains common. While over a dozen genes can be involved, certain ones are often seen in CIE:

  • ALOX12B and ALOXE3: These genes are very strongly associated with the CIE appearance [10]. They help oxidize (process) the lipids that seal the skin barrier. When they don’t work, the skin often appears redder and the scales are finer [11][12].
  • TGM1: This gene is most commonly linked to the Lamellar Ichthyosis phenotype, but can also cause CIE. It provides the instructions for an enzyme that “staples” proteins together to form the skin’s protective envelope [13][14].
  • ABCA12, CYP4F22, and PNPLA1: These genes are involved in transporting or building the lipid barrier [15][7]. Mutations in these can lead to a variety of appearances along the spectrum [16][17].

The Role and Limits of Genetic Testing

Because different genes can cause skin that looks very similar, genetic testing is used to explore the exact cause, but it has limitations [18].

  1. Probabilistic Results: Genotype-phenotype correlations are probabilistic, meaning having a specific gene variant does not always guarantee a specific clinical severity.
  2. Uncertainty: Sometimes tests return a “variant of uncertain significance”, meaning a change was found but science doesn’t yet know if it causes the disease. A negative or uncertain result does not exclude ARCI.
  3. Family Planning: ARCI is autosomal recessive. When both parents carry a pathogenic variant in the same relevant autosomal-recessive gene, there is a 25% chance in each future pregnancy that the child will have ichthyosis [19][20]. Carrier status and reproductive options should be discussed with a genetics professional [21].

Common questions in this guide

How are CIE and lamellar ichthyosis related?
Congenital ichthyosiform erythroderma, or CIE, and lamellar ichthyosis, or LI, are clinical presentations within the autosomal recessive congenital ichthyosis spectrum. CIE usually has more widespread redness and finer, whitish scales, while LI often has less redness and thicker, darker scales. Many people have overlapping features, and the appearance can change over time.
Which genes are commonly linked to CIE?
ALOX12B and ALOXE3 are strongly associated with the CIE pattern. TGM1 is more often linked with lamellar ichthyosis but can also cause CIE, while ABCA12, CYP4F22, and PNPLA1 help build or transport skin-barrier lipids and can produce different appearances across the ARCI spectrum.
What can genetic testing tell me about CIE?
Genetic testing may identify the gene change responsible for ARCI and can help clarify the molecular cause of a person’s skin condition. The result does not always predict how severe the condition will be or exactly how the skin will look, because gene-to-feature relationships are not absolute. A clinical examination remains important.
Does a negative or uncertain genetic test rule out ARCI?
No. Because many genes can be involved and some changes are not yet understood, a negative result or a variant of uncertain significance does not exclude ARCI. A genetics professional can explain what the result means and whether additional evaluation may be appropriate.
What is the chance of having a child with ichthyosis if both parents are carriers?
When both parents carry a disease-causing change in the same autosomal-recessive gene, each pregnancy has a 25% chance of resulting in a child with ichthyosis. The exact interpretation depends on the gene and variants involved, so carrier results and reproductive options should be discussed with a genetic counselor.
What does a variant of uncertain significance mean on an ARCI test?
It means the test found a genetic change, but current evidence is not enough to determine whether it causes ARCI. This result is not proof that the change caused the condition, and a clinician or genetic counselor can interpret it alongside the person’s clinical findings.

Get notified when new evidence is published on Congenital ichthyosiform erythroderma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (21)
  1. 1

    Spectrum of Autosomal Recessive Congenital Ichthyosis in Scandinavia: Clinical Characteristics and Novel and Recurrent Mutations in 132 Patients.

    Pigg MH, Bygum A, Gånemo A, et al.

    Acta dermato-venereologica 2016; (96(7)):932-937 doi:10.2340/00015555-2418.

    PMID: 27025581
  2. 2

    Autosomal recessive congenital ichthyosis: Genomic landscape and phenotypic spectrum in a cohort of 125 consanguineous families.

    Youssefian L, Vahidnezhad H, Saeidian AH, et al.

    Human mutation 2019; (40(3)):288-298 doi:10.1002/humu.23695.

    PMID: 30578701
  3. 3

    Dental Treatment of a Child Suffering from Non-bullous Congenital Ichthyosiform Erythroderma under General Anesthesia.

    Choudhary R, Satish V

    International journal of clinical pediatric dentistry 2015; (8(2)):157-62 doi:10.5005/jp-journals-10005-1305.

    PMID: 26379388
  4. 4

    Cross-Sectional Study on Autosomal Recessive Congenital Ichthyoses: Association of Genotype with Disease Severity, Phenotypic, and Ultrastructural Features in 74 Italian Patients.

    Diociaiuti A, Corbeddu M, Rossi S, et al.

    Dermatology (Basel, Switzerland) 2024; (240(3)):397-413 doi:10.1159/000536366.

    PMID: 38588653
  5. 5

    Collodion Baby with TGM1 gene mutation.

    Sharma D, Gupta B, Shastri S, et al.

    International medical case reports journal 2015; (8()):205-8 doi:10.2147/IMCRJ.S91517.

    PMID: 26451124
  6. 6

    Could "Islets of Sparing" Be a Clue for Neutral Lipid Storage Disease with Ichthyosis in Patients with Congenital Ichthyosiform Erythroderma?

    Demir FT, Cayhan B, Karaoglan C, et al.

    Indian journal of dermatology 2022; (67(5)):579-582 doi:10.4103/ijd.ijd_1154_20.

    PMID: 36865854
  7. 7

    Elucidation of the Synthetic Mechanism of Acylceramide, an Essential Lipid for Skin Barrier Function.

    Ohno Y

    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2017; (137(10)):1201-1208 doi:10.1248/yakushi.17-00126.

    PMID: 28966260
  8. 8

    PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.

    Hirabayashi T, Anjo T, Kaneko A, et al.

    Nature communications 2017; (8()):14609 doi:10.1038/ncomms14609.

    PMID: 28248300
  9. 9

    PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier.

    Pichery M, Huchenq A, Sandhoff R, et al.

    Human molecular genetics 2017; (26(10)):1787-1800 doi:10.1093/hmg/ddx079.

    PMID: 28369476
  10. 10

    Molecular epidemiology of non-syndromic autosomal recessive congenital ichthyosis in a Middle-Eastern population.

    Mohamad J, Samuelov L, Malchin N, et al.

    Experimental dermatology 2021; (30(9)):1290-1297 doi:10.1111/exd.14345.

    PMID: 33786896
  11. 11

    Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients.

    Hotz A, Kopp J, Bourrat E, et al.

    Genes 2021; (12(1)) doi:10.3390/genes12010080.

    PMID: 33435499
  12. 12

    SDR9C7 catalyzes critical dehydrogenation of acylceramides for skin barrier formation.

    Takeichi T, Hirabayashi T, Miyasaka Y, et al.

    The Journal of clinical investigation 2020; (130(2)):890-903.

    PMID: 31671075
  13. 13

    Novel Compound Heterozygous Variants in TGM1 and CYP4F22 in Two Newborns with Non-Syndromic Epidermal Differentiation Disorders (TGM1-nEDD and CYP4F22-nEDD).

    Serra G, Barbera G, Antona V, et al.

    Journal of clinical medicine 2026; (15(14)) doi:10.3390/jcm15145556.

    PMID: 42513470
  14. 14

    Analysis of the expression of transglutaminases in the reconstructed human epidermis using a three-dimensional cell culture.

    Teshima H, Kato M, Tatsukawa H, Hitomi K

    Analytical biochemistry 2020; (603()):113606 doi:10.1016/j.ab.2020.113606.

    PMID: 32004543
  15. 15

    Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis.

    Akiyama M

    Journal of dermatological science 2017; (88(1)):3-9 doi:10.1016/j.jdermsci.2017.06.002.

    PMID: 28623042
  16. 16

    Mutational Spectrum of the ABCA12 Gene and Genotype-Phenotype Correlation in a Cohort of 64 Patients with Autosomal Recessive Congenital Ichthyosis.

    Hotz A, Kopp J, Bourrat E, et al.

    Genes 2023; (14(3)) doi:10.3390/genes14030717.

    PMID: 36980989
  17. 17

    CYP4F22-Related Autosomal Recessive Congenital Ichthyosis Associated With Hirschsprung Disease and Bartter-Like Renal Manifestations.

    Alqahtani JM

    Journal of medical cases 2026; (17(10)):599-603 doi:10.14740/jmc5388.

    PMID: 42730452
  18. 18

    Spectrum of ichthyoses in an Austrian ichthyosis cohort from 2004 to 2017.

    Seidl-Philipp M, Schatz UA, Gasslitter I, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2020; (18(1)):17-25 doi:10.1111/ddg.13968.

    PMID: 31642606
  19. 19

    Gene-Targeted Next Generation Sequencing Identifies PNPLA1 Mutations in Patients with a Phenotypic Spectrum of Autosomal Recessive Congenital Ichthyosis: The Impact of Consanguinity.

    Vahidnezhad H, Youssefian L, Saeidian AH, et al.

    The Journal of investigative dermatology 2017; (137(3)):678-685 doi:10.1016/j.jid.2016.11.012.

    PMID: 27884779
  20. 20

    Variants in the PNPLA1 Gene in Families with Autosomal Recessive Congenital Ichthyosis Reveal Clinical Significance.

    Ahmad F, Ahmed I, Alam Q, et al.

    Molecular syndromology 2021; (12(6)):351-361 doi:10.1159/000516943.

    PMID: 34899144
  21. 21

    Novel compound heterozygous variants in TGM1 with the lethal neonatal collodion baby and autosomal recessive congenital ichthyosis.

    Pan Y, Xu H, Zeng M, et al.

    Archives of dermatological research 2025; (317(1)):611 doi:10.1007/s00403-025-03796-w.

    PMID: 40119962

This page explains CIE genetics and inheritance for informational purposes only and does not constitute medical advice. A dermatologist, geneticist, or genetic counselor can interpret your results and discuss family-planning options.

Guide contents Congenital ichthyosiform erythroderma
Research & Literature
01 Understanding the Diagnosis 03 Daily Skin Management